Enhancing patient adherence to improve outcomes with oral chemotherapy

U.S. Pharmacist

Volumn 32, Issue 10, 2007, Pages 1-8

  Boyle, Deborah ^a   Bubalo, Joseph ^b,c  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b Department of Medicine ^*  (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; IMATINIB; PREDNISONE;

ARTICLE; ATTITUDE TO ILLNESS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COGNITIVE DEFECT; DOCTOR PATIENT RELATION; DRUG MONITORING; DRUG SAFETY; DRUG UTILIZATION; FAMILY COUNSELING; HEALTH CARE COST; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; MOTIVATION; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PERCEPTION; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; RISK FACTOR; SOCIAL INTERACTION; TREATMENT REFUSAL; VISUAL IMPAIRMENT;

EID: 47749116502     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (21)

1. Bedell CH. A changing paradigm for cancer treatment: The advent of new oral chemotherapy agents. Clin J Oncol Nurs. 2003;7 supplement(6):5-9.
2. Blasdel C, Bubalo J. Adherence to oral cancer therapies: meeting the challenge of new patient care needs. Oncology Special Edition (Annual Special Report from the publisher of Clinical Oncology News, 2006), conference edition.
3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497.
4. Goldberg RM, Rothenberg ML, Van CE, et al. The continuum of care: a paradigm for the management of metastatic colorectal cancer. Oncologist. 2007;12(1):38-50.
5. Hartigan K. Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs. 2003;7(6 Suppl):21-24.
6. Partridge AH, Avorn J, Wang PS, et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002;94(9):652-661.
7. Escalada P, Griffiths P. Do people with cancer comply with oral chemotherapy treatments? Br J Community Nurs. 2006; 11 (12):532-536.
8. Lebovits AH, Strain A Schleifer SJ, et al. Patient noncompliance with self-administered chemotherapy. Cancer. 1990;65(1):17-22.
9. Nilsson JL, Andersson K, Bergkvist A, et al. Refill adherence to repeat prescriptions of cancer drugs to ambulatory patients. Eur J Cancer Care (Engl). 2006; 15(3):235-237.
10. Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987;5(9):1469-1476.
11. Tsang J, Rudychev I, Pescatore SL. Prescription compliance and persistency in chronic myelogenous leukemia (CML) and gastrointestinal stromal tumor (GIST) patients (pts) on imatinib (IM). J Clin Oncol. 2006;24(18S):330s. Abstract.
12. Wood WC, Budman DR, Korzun AH, et al. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med. 1994-1330(18): 1253-1259.
13. Mayer RJ, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med. 1994;331(14):896-903.
14. Bonadonna G, Valagussa P. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med. 1981;304(1):10-15.
15. Henk HJ, Thomas SK, Feng W, et al. The impact of non-compliance with imatinib (IM) therapy on health care costs. J Clin Oncol. 2006;24(18S):321s. Abstract.
16. Vermeire E, Hearnshaw H, Van RP, et al. Patient adherence to treatment: three decades of research, A comprehensive review. J Clin Pharmacol. 2001;26(5):331-342.
17. Simpson RJ, Jr. Challenges for improving medication adherence. JAMA. 2006;296(21):2614-2616.
18. Haynes RB, Wang E, Da Mota Gomes M. A critical review of interventions to improve compliance with prescribed medications. Patient Educ Couns. 1987; 10: 155-166.
19. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006;296(21):2563-2571.
20. Walker EA, Molitch M, Kramer MK, et al. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diabetes Care. 2006;29(9):1997-2002.
21. Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714-725.